Preliminary Results from TRUST: A Phase II Clinical Study to Investigate Taletrectinib in Treating Patients with ROS1 Fusion Positive Non-small Cell Lung Cancer (NSCLC) (pdf)

Preliminary Results from TRUST: A Phase II Clinical Study to Investigate Taletrectinib in Treating Patients with ROS1 Fusion Positive Non-small Cell Lung Cancer (NSCLC) (pdf) Read More »